Last reviewed · How we verify
ZPL-3893787
At a glance
| Generic name | ZPL-3893787 |
|---|---|
| Also known as | ZPL389 |
| Sponsor | Ziarco Pharma Ltd |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis (PHASE2)
- A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |